Evidence map›Paper›PMID 18783314›Full record

ArticleThe Journal of infectious diseases2008

HIV-1 tropism, disease progression, and clinical management.

Harold Burger, Donald Hoover

Abstract readCommentEditorial
PubMed Publisher
In one paragraph

Article in The Journal of infectious diseases, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Harold Burger
Donald Hoover

Funding

Women's Interagency HIV Study (WIHS-V)U01AI035004 · NIAID · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI ANASTOS, KATHRYN M., SHARMA, ANJALI · 1993 to 2018
$65.7M
Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
HIV Compartmentalization in Women:Virus &CTL ResponseR01AI052015 · NIAID · WADSWORTH CENTER · PI WEISER, BARBARA · 2002 to 2006
$2.0M
METABOLIC EFFECTS OF PROTEASE INHIBITORS IN HIV DISEASER01DK054615 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MULLIGAN, KATHLEEN · 1998 to 2002
$1.0M
NIAID NIH HHS AI51519NIAID NIH HHS R01-AI52015NIAID NIH HHS U01-AI34004NIAID NIH HHS U01-AI35004NIDDK NIH HHS DK54615
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-HIV AgentsCD4 Lymphocyte CountDisease ProgressionHIV-1HIV AntibodiesHIV InfectionsHumansMaleReceptors, CCR5Receptors, CXCR4Anti-HIV AgentsHIV AntibodiesReceptors, CCR5Receptors, CXCR4

Identifiers

PMID18783314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.